Literature DB >> 6337682

Role of the Venereal Disease Research Laboratory test in the detection of syphilis.

P Diggory.   

Abstract

Of 9733 consecutive serological samples received by Portsmouth and Southampton Public Health Laboratories (PHL) and tested for syphilis, 190 (140 from men and 50 from women) gave positive results. Thirty new cases of syphilis were identified. Most sera were tested initially by both a specific antibody test (the Treponema pallidum haemaglutination (TPHA) test) and a cardiolipin test (the Venereal Disease Research Laboratory (VDRL) test). Among the 14 patients whose sera gave VDRL-positive but TPHA-negative results, 12 sera gave false-positive results. The sera of 90 patients gave TPHA-positive but VDRL-negative results; sera from only seven of these patients gave false-positive results. The VDRL test is very unlikely to identify a new case of syphilis where a TPHA test has failed to do so. The results of the survey suggest that the VDRL test should be withdrawn from initial testing for syphilis except where early primary disease is suspected.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6337682      PMCID: PMC1046122          DOI: 10.1136/sti.59.1.8

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


  12 in total

1.  Biologically false positive serologic tests for syphilis; type, incidence, and cause.

Authors:  J E MOORE; C F MOHR
Journal:  J Am Med Assoc       Date:  1952-10-04

2.  Specificity, sensitivity, and diagnostic value of the TPHA test.

Authors:  J Lesiński; J Krach; E Kadziewicz
Journal:  Br J Vener Dis       Date:  1974-10

3.  Treponema pallidum haemagglutination test as a screening procedure for the diagnosis of syphilis.

Authors:  H Young; C Henrichsen; D H Robertson
Journal:  Br J Vener Dis       Date:  1974-10

4.  Treponema pallidum haemagglutination test for syphilis. Evaluation of a modified micro-method.

Authors:  N A Johnston
Journal:  Br J Vener Dis       Date:  1972-12

5.  Treponema pallidum haemagglutination assay in the routine serodiagnosis of treponemal disease.

Authors:  P O'Neill; R W Warner; C S Nicol
Journal:  Br J Vener Dis       Date:  1973-10

6.  Usefulness of the hemagglutination test using Treponema pallidum antigen (TPHA) for the serodiagnosis of syphilis.

Authors:  T Tomizawa; S Kasamatsu; S I Yamaya
Journal:  Jpn J Med Sci Biol       Date:  1969-12

7.  Specificity of the FTA-ABS test for syphilis.

Authors:  D M Mackey; E V Price; J M Knox; A Scotti
Journal:  JAMA       Date:  1969-03-03       Impact factor: 56.272

8.  Fluorescent treponemal antibody-absorption (FTA-ABS) test for syphilis.

Authors:  W E Deacon; J B Lucas; E V Price
Journal:  JAMA       Date:  1966-11-07       Impact factor: 56.272

9.  Homosexuality and sexually transmitted diseases.

Authors:  J L Fluker
Journal:  Br J Hosp Med       Date:  1981-09

10.  Treatment of secondary syphilis: an evaluation of 204 patients.

Authors:  N J Fiumara
Journal:  Sex Transm Dis       Date:  1977 Jul-Sep       Impact factor: 2.830

View more
  6 in total

1.  VDRL titres in early syphilis before and after treatment.

Authors:  S Talwar; M A Tutakne; V D Tiwari
Journal:  Genitourin Med       Date:  1992-04

2.  Interpreting serological tests for syphilis.

Authors:  J A Geddes
Journal:  Can Fam Physician       Date:  1987-08       Impact factor: 3.275

3.  The VDRL test in the diagnosis of syphilis.

Authors: 
Journal:  Br J Vener Dis       Date:  1983-10

4.  Biological false positive serological tests for syphilis in the Jamaican population.

Authors:  M F Smikle; O B James; P Prabhakar
Journal:  Genitourin Med       Date:  1990-04

5.  Evaluation of the usefulness of Treponema pallidum hemagglutination test in the diagnosis of syphilis in weak reactive Venereal Disease Research Laboratory sera.

Authors:  Manju Bala; Aman Toor; Meenakshi Malhotra; Monika Kakran; Sumathi Muralidhar; V Ramesh
Journal:  Indian J Sex Transm Dis AIDS       Date:  2012-07

6.  Antenatal screening for syphilis at a tertiary care hospital in Riyadh.

Authors:  Zahid Shakoor
Journal:  Ann Saudi Med       Date:  2004 Jul-Aug       Impact factor: 1.526

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.